-
AVIR Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Atea Pharmaceuticals (AVIR)
Company Profile
Quarter (USD) | Dec 24 | Sep 24 | Jun 24 | Mar 24 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 64.70 mm | 64.70 mm | 64.70 mm | 64.70 mm | 64.70 mm | 64.70 mm |
Cash burn (monthly) | 11.26 mm | 6.59 mm | 13.01 mm | 16.08 mm | 10.13 mm | 11.29 mm |
Cash used (since last report) | 25.87 mm | 15.16 mm | 29.90 mm | 36.96 mm | 23.29 mm | 25.95 mm |
Cash remaining | 38.83 mm | 49.54 mm | 34.80 mm | 27.74 mm | 41.41 mm | 38.74 mm |
Runway (months of cash) | 3.4 | 7.5 | 2.7 | 1.7 | 4.1 | 3.4 |
13F holders | Current |
---|---|
Total holders | 109 |
Opened positions | 15 |
Closed positions | 17 |
Increased positions | 39 |
Reduced positions | 32 |
13F shares | Current |
---|---|
Total value | 184.10 bn |
Total shares | 76.17 mm |
Total puts | 38.70 k |
Total calls | 7.60 k |
Total put/call ratio | 5.1 |
Largest owners | Shares | Value |
---|---|---|
BlackRock | 9.06 mm | $30.36 bn |
BML Capital Management | 7.61 mm | $25.49 bn |
BML Investment Partners | 6.81 mm | $22.26 mm |
FMR | 6.43 mm | $21.52 bn |
Sommadossi Jean-Pierre | 5.93 mm | $24.12 mm |
Tang Capital Management | 4.79 mm | $16.04 bn |
Vanguard | 4.67 mm | $15.63 bn |
Tang Capital Partners | 4.03 mm | $11.29 mm |
EcoR1 Capital | 3.34 mm | $11.19 bn |
Bain Capital Life Sciences Fund II | 3.18 mm | $100.35 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
20 Feb 25 | Kirsch Arthur S | Stock Option Common Stock | Grant | Acquire A | No | No | 3.14 | 164,800 | 517.47 k | 164,800 |
31 Jan 25 | Janet MJ Hammond | Common Stock | Payment of exercise | Dispose F | No | No | 3.06 | 14,134 | 43.25 k | 81,388 |
31 Jan 25 | Janet MJ Hammond | Common Stock | Grant | Acquire A | No | No | 0 | 11,250 | 0.00 | 95,522 |
31 Jan 25 | Janet MJ Hammond | Common Stock | Option exercise | Acquire M | No | No | 0 | 46,800 | 0.00 | 84,272 |
31 Jan 25 | Janet MJ Hammond | Stock Option Common Stock | Grant | Acquire A | No | No | 3.06 | 200,000 | 612.00 k | 200,000 |
31 Jan 25 | Janet MJ Hammond | RSU Common Stock | Grant | Acquire A | No | No | 0 | 11,250 | 0.00 | 11,250 |
31 Jan 25 | Janet MJ Hammond | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 46,800 | 0.00 | 46,800 |
31 Jan 25 | Maria Arantxa Horga | Common Stock | Payment of exercise | Dispose F | No | No | 3.06 | 16,071 | 49.18 k | 60,876 |
31 Jan 25 | Maria Arantxa Horga | Common Stock | Grant | Acquire A | No | No | 0 | 9,750 | 0.00 | 76,947 |
31 Jan 25 | Maria Arantxa Horga | Common Stock | Option exercise | Acquire M | No | No | 0 | 41,533 | 0.00 | 67,197 |